Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Invivyd, Inc. | 50,000 | reported | 19 May 2026 | tx 4+250,000 |
| Vericel Corp | 21,800 | reported | 13 May 2026 | tx 63+285,050−64,700 |
| ACCELERON PHARMA INC | 0 | reported | 19 Nov 2021 | tx 291+743,141−1,002,642 |
| Decibel Therapeutics, Inc. | 0 | reported | 25 Sept 2023 | tx 6+30,000−30,000 |
| PRAECIS PHARMACEUTICALS INC | 0 | reported | 08 Feb 2007 | tx 22+148,700−221,200 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Invivyd, Inc. | 50,000 | 0.00 USD | deriv |
| 13 May 2026 | EXERCISE | Vericel Corp | 3,500 | 2.63 USD | 10b5-1 |
| 13 May 2026 | SALE | Vericel Corp | 3,500 | 32.83 USD | 10b5-1 |
| 13 May 2026 | EXERCISE | Vericel Corp | 3,500 | 13.05 USD | 10b5-1 |
| 13 May 2026 | SALE | Vericel Corp | 3,500 | 32.82 USD | 10b5-1 |
| 13 May 2026 | EXERCISE | Vericel Corp | 3,500 | 0.00 USD | 10b5-1deriv |
| 13 May 2026 | EXERCISE | Vericel Corp | 3,500 | 0.00 USD | 10b5-1deriv |
| 11 Feb 2026 | EXERCISE | Vericel Corp | 7,000 | 2.63 USD | |
| 11 Feb 2026 | SALE | Vericel Corp | 7,000 | 34.66 USD | |
| 11 Feb 2026 | EXERCISE | Vericel Corp | 7,000 | 0.00 USD | deriv |
| 19 Nov 2025 | PURCHASE | Invivyd, Inc. | 50,000 | 2.50 USD | |
| 10 Nov 2025 | EXERCISE | Vericel Corp | 7,000 | 2.63 USD | |
| 10 Nov 2025 | SALE | Vericel Corp | 7,000 | 38.59 USD | |
| 10 Nov 2025 | EXERCISE | Vericel Corp | 7,000 | 0.00 USD | deriv |
| 06 Aug 2025 | EXERCISE | Vericel Corp | 7,000 | 2.76 USD | |
| 06 Aug 2025 | SALE | Vericel Corp | 7,000 | 35.92 USD | |
| 06 Aug 2025 | EXERCISE | Vericel Corp | 7,000 | 0.00 USD | deriv |
| 20 May 2025 | GRANT_AWARD | Invivyd, Inc. | 50,000 | 0.00 USD | deriv |
| 07 May 2025 | SALE | Vericel Corp | 7,000 | 39.98 USD | |
| 07 May 2025 | EXERCISE | Vericel Corp | 7,000 | 2.76 USD | |
| 07 May 2025 | EXERCISE | Vericel Corp | 7,000 | 0.00 USD | deriv |
| 30 Apr 2025 | EXERCISE | Vericel Corp | 3,200 | — | |
| 30 Apr 2025 | EXERCISE | Vericel Corp | 3,200 | 0.00 USD | deriv |
| 30 Apr 2025 | GRANT_AWARD | Vericel Corp | 8,000 | 0.00 USD | deriv |
| 30 Apr 2025 | GRANT_AWARD | Vericel Corp | 3,200 | 0.00 USD | deriv |